http://purl.org/np/RAn_cIYPe9... RAn_cIYPe9

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/1999/02/22-rdf-syntax-ns#subject subject

https://identifiers.org/DRUGBANK:DB00656 DRUGBANK:DB00656

0000-0002-7641-6446

2021-08-25T17:50:47.226Z

http://purl.org/np/RAn_cIYPe9... RAn_cIYPe9

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/1999/02/22-rdf-syntax-ns#object object

http://purl.obolibrary.org/obo/MONDO_0013600 MONDO_0013600

0000-0002-7641-6446

2021-08-25T17:50:47.226Z

http://purl.org/np/RAn_cIYPe9... RAn_cIYPe9

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

https://w3id.org/biolink/vocab/publications publications

https://pubmed.ncbi.nlm.nih.gov/30024873 pubmed.ncbi.nlm.nih.gov/30024873

0000-0002-7641-6446

2021-08-25T17:50:47.226Z

http://purl.org/np/RAn_cIYPe9... RAn_cIYPe9

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/1999/02/22-rdf-syntax-ns#type type

http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement Statement

0000-0002-7641-6446

2021-08-25T17:50:47.226Z

http://purl.org/np/RAn_cIYPe9... RAn_cIYPe9

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

https://w3id.org/biolink/vocab/has_population_context has_population_context

http://purl.org/np/RAn_cIYPe9...#context context

0000-0002-7641-6446

2021-08-25T17:50:47.226Z

http://purl.org/np/RAn_cIYPe9... RAn_cIYPe9

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate predicate

https://w3id.org/biolink/vocab/treats treats

0000-0002-7641-6446

2021-08-25T17:50:47.226Z

http://purl.org/np/RAn_cIYPe9... RAn_cIYPe9

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

https://w3id.org/biolink/vocab/relation relation

https://w3id.org/um/neurodkg/OffLabelIndication OffLabelIndication

0000-0002-7641-6446

2021-08-25T17:50:47.226Z

http://purl.org/np/RAn_cIYPe9... RAn_cIYPe9

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/2000/01/rdf-schema#label label

The most common off-label uses were for manic-depressive psychosis treated with citalopram and primary insomnia treated with trazodone. Several patient and clinician characteristics were positively associated with off-label prescribing, including seeing a psychiatrist (OR: 1.06, 95% CI, 1.01–1.12; p = 0.03) instead of another type of clinician, the office visit taking place in the Western region of the country (OR: 1.09, 95% CI, 1.01–1.17; p = 0.02), and the patient having 3 or more chronic conditions (OR: 1.12, 95% CI, 1.02–1.14; p = 0.003).

0000-0002-7641-6446

2021-08-25T17:50:47.226Z

http://purl.org/np/RAn_cIYPe9... RAn_cIYPe9

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

https://w3id.org/biolink/vocab/provided_by provided_by

https://w3id.org/um/NeuroDKG NeuroDKG

0000-0002-7641-6446

2021-08-25T17:50:47.226Z